Polypeptide compounds containing D-2-alkyltryptophan capable of

Details Polypeptide compounds containing D-2-alkyltryptophan capable of Polypeptide compounds containing D-2-alkyltryptophan capable of

1995-09-20

1998-08-18

Davenport, Avis M.

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

6 to 7 amino acid residues in defined sequence

530300, 530330, 514 16, 514 17, A61K 3800, A61K 3802, C07K 500, C07K 700

Patent

active

057959579

ABSTRACT:
Novel peptides comprising D-2-alkyltryptophan, useful for promoting growth hormone release, compositions comprising such peptides and methods of using such compositions are described. In a preferred embodiment of the invention, the D-2-alkyl tryptophan is D-2-methyltryptophan.

REFERENCES:
patent: 3316260 (1967-04-01), Shen et al.
patent: 4223019 (1980-09-01), Momany
patent: 4223020 (1980-09-01), Momany
patent: 4223021 (1980-09-01), Momany
patent: 4224316 (1980-09-01), Momany
patent: 4226857 (1980-10-01), Momany
patent: 4228155 (1980-10-01), Momany
patent: 4228156 (1980-10-01), Momany
patent: 4228157 (1980-10-01), Momany
patent: 4228158 (1980-10-01), Momany
patent: 4410512 (1983-10-01), Bowers
patent: 4410513 (1983-10-01), Momany
patent: 4411890 (1983-10-01), Momany
patent: 4839344 (1989-06-01), Bowers et al.
Deghenghi et al., Life Sciences, vol. 54, No. 18, pp. 1321-1328.
G. Tolis et al. "Growth Hormone Release in Thalassemic Patients by a New GH-Releasing Peptide Administered Intravenously or Orally". 75th Endocrine Society meeting, Las Vegas, NE, Jun. 9, 1993.
R. Deghenghi et al. "Structure-Activity Studies with Hexarelin and Related GH-Releasing Peptides" 3rd Intl. Pituitary Congress, Marina de Rey, CA, Jun. 13-15, 1993.
E. Arvat et al. "GH-Releasing Activity of Hexarelin, A New Wynthetic Hexapeptide, After Intravenous, Subcutaneous, Intranasal and Oral Administration In Man" Giornate Endocrinologiche Pisane, Pisa (Italy) Jun. 28-29, 1993.
L.K. Conley et al., Biological Potency of Hexarelin (EP23905) "Initial Studies on Oral Activity", presented 1992.
W.B. Wehrenerg et al., "Biological Potency of Hexarelin (EP23905), A New Growth Hormone-Releasing Peptide", presented 1992.
R. Deghenghi et al. "Hexarelin (EP23905)--A Sensitive Growth Hormone Releasing Peptide", presented in Milan, Italy, Sep. 1992.
L.K. Conley et al., "Studies on the Mechanism of Action of Hexarelin and GHRP-6", presented at International Symposium on Growth Hormone II, Basic Clinical Aspects, in Partpon Springs, Florida, Dec. 2-3, 1992.
B.P. Imbimbo et al., "Growth Hormone Releasing Activity of Hexarelin in Humans: A Dose-Responsive Study", presented at the International Symposium on Growth Hormone II, Basic Clinical Aspects, in Tarpon Springs, Florida, Dec. 3-6, 1992.
Silver et al., "Scleroderma, Fascities, and Eosinophillia Associated With the Igestion of Tryptophan", The New England Journal of Medicine, 332: No. 13, Mar. 29, 1990.
Karten et al., "Gonadotropin-Releasing Hormone Analog Design, Structure-Function Studies Toward the Development Agonists and Antagonists: Rationale and Perspective", Endocrine Reviews, 7(1):44-66(1986).
Yabe et al., "Synthesis and Biological Activity of LH-RH Analogs Substituted by Alkyltryptophans at Position 3", Chem Pharm. Bull, vol. 27, No. 8, (1979).
Pailthrope et al., Chenical Abstracts 79:400 (1973).
S. Majima, "E.W. Biologisches Verfahten der d-Tryptophandarstellans", Hoppe-Seyler's Z. Physiol Chem. 243:250 (1936).

Affiliated with

Also associated with

Rating

Polypeptide compounds containing D-2-alkyltryptophan capable of does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptide compounds containing D-2-alkyltryptophan capable of , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide compounds containing D-2-alkyltryptophan capable of will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1115642